MicroRNA miR-27a as a possible regulator of anti-inflammatory macrophage phenotype in preeclamptic placenta

Introduction: The role of the TGFβ signaling pathway, an important cascade responsible for the anti-inflammatory polarization of macrophages, in the development of both early- and late-onset preeclampsia (eoPE and loPE), remains poorly understood. In this study, we examined the components of the TGFβ signaling cascade and macrophage markers within placental tissue in normal pregnancy and in PE. Methods: Patients with eoPE, loPE, and normal pregnancy were enrolled in the study (n = 10 in each group). Following techniques were used for the investigation: immunohistochemistry analysis, western blotting, qRT-PCR, isolation of monocytes by magnetic sorting, transfection, microRNA sequencing, and bioinformatic analysis. Results: We observed a significant decrease in the anti-inflammatory macrophage marker CD206 in the loPE group, alongside with a significant down-regulation of CD206 protein production in both eoPE and loPE groups. The level of CD68-positive cells and relative levels of CD163 and MARCO production were comparable across the groups. However, we identified a significant decrease in the TGFβ receptor 2 production and its gene expression in the PE group. Further analysis revealed a link between TGFBR2 and MRC1 (CD206) genes through a single miRNA, hsa-miR-27a-3p. Transfecting CD14-derived macrophages with the hsa-miR-27a-3p mimic significantly changed TGFBR2 production, indicating the potential role of this miRNA in regulating the TGFβ signaling pathway. We also revealed the up-regulation of hsa-miR-27a-5p and hsa-miR-27a-3p in the trophoblast BeWo b30 cell line under the severe hypoxia condition and the fact that TGFBR2 3′ UTR could serve as a potential target for these miRNAs. Discussion: Our findings uncover a novel potential therapeutic target for managing patients with PE, significantly contributing to a deeper comprehension of the underlying mechanisms involved in the development of this pathology. © 2023 Elsevier Ltd

Authors
Vishnyakova P. , Gantsova E. , Kiseleva V. , Lazarev D. , Knyazev E. , Poltavets A. , Iskusnykh M. , Muminova K. , Potapova A. , Khodzhaeva Z. , Elchaninov A. , Fatkhudinov T. , Sukhikh G.
Journal
Publisher
W.B. Saunders Ltd
Language
English
Pages
151-161
Status
Published
Volume
145
Year
2024
Organizations
  • 1 National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, Moscow, Russian Federation
  • 2 Research Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia, Moscow, Russian Federation
  • 3 Pirogov Russian National Research Medical University (Pirogov Medical University), Moscow, Russian Federation
  • 4 Faculty of Biology and Biotechnology, HSE University, Moscow, Russian Federation
  • 5 Laboratory of Microfluidic Technologies for Biomedicine, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russian Federation
  • 6 Avtsyn Research Institute of Human Morphology of Federal state budgetary scientific institution “Petrovsky National Research Centre of Surgery”, Moscow, Russian Federation
Keywords
CD206; Macrophages; microRNA; miR-27a; PE; Preeclampsia; TGFβ; TGFβ receptor 1; TGFβ receptor 2
Share

Other records

Киричук Анатолий Александрович
2022. 48 p.